CDKN2D
Cyclin-dependent kinase 4 inhibitor D
Also known as: CDN2D_HUMAN, INK4D, p19
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55273
- Gene
- CDKN2D
- Ensembl
- ENSG00000129355
- Chromosome
- 19
- Canonical length
- 166 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the INK4 family of cyclin-dependent kinase inhibitors. This protein has been shown to form a stable complex with CDK4 or CDK6, and prevent the activation of the CDK kinases, thus function as a cell growth regulator that controls cell cycle G1 progression. The abundance of the transcript of this gene was found to oscillate in a cell-cycle dependent manner with the lowest expression at mid G1 and a maximal expression during S phase. The negative regulation of the cell cycle involved in this protein was shown to participate in repressing neuronal proliferation, as well as spermatogenesis. Two alternatively spliced variants of this gene, which encode an identical protein, have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
166 residues, UniProt reviewed canonical sequence.
>P55273|CDKN2D
1 MLLEEVRAGD RLSGAAARGD VQEVRRLLHR ELVHPDALNR FGKTALQVMM FGSTAIALEL
61 LKQGASPNVQ DTSGTSPVHD AARTGFLDTL KVLVEHGADV NVPDGTGALP IHLAVQEGHT
121 AVVSFLAAES DLHRRDARGL TPLELALQRG AQDLVDILQG HMVAPLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDKN2D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 268 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 268 nTPM
- cerebral cortex: 128 nTPM
- amygdala: 111 nTPM
- basal ganglia: 92 nTPM
- hippocampal formation: 90 nTPM
- thymus: 73 nTPM
Single-cell type
- megakaryocytes: 2,263 nCPM
- platelets: 1,543 nCPM
- neutrophils: 561 nCPM
- neutrophil progenitors: 222 nCPM
- late primary spermatocytes: 148 nCPM
- pdcs: 140 nCPM
Immune cell
- basophil: 144 nTPM
- neutrophil: 141 nTPM
- eosinophil: 80 nTPM
- memory B-cell: 57 nTPM
- plasmacytoid DC: 51 nTPM
- naive B-cell: 50 nTPM
Brain region
- cerebral cortex: 83 nTPM
- basal ganglia: 67 nTPM
- hippocampal formation: 62 nTPM
- pons: 61 nTPM
- amygdala: 60 nTPM
- hypothalamus: 60 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.39
- gnomAD pLI
- 0.49
- gnomAD missense Z
- 1.13
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagic cell death
- DNA synthesis involved in DNA repair
- negative regulation of cell growth
- negative regulation of cell population proliferation
- negative regulation of G1/S transition of mitotic cell cycle
- negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage
- regulation of G1/S transition of mitotic cell cycle
- response to retinoic acid
- response to UV
- response to vitamin D
- sensory perception of sound
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDKN2D in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDKN2D as an antibody target. Whether an autoantibody or antibody against CDKN2D could matter depends on whether native CDKN2D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDKN2D is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDKN2D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...